Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bellerophon Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
BLPH
Over the counter
8731
http://www.bellerophon.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bellerophon Therapeutics Inc
Bellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should Know
- Jul 6th, 2023 10:00 pm
Bellerophon Therapeutics (BLPH) Stock Sinks As Market Gains: What You Should Know
- Jun 29th, 2023 10:00 pm
7 Must-Have Stocks to Buy and Hold for a Secure Future
- Jun 19th, 2023 10:00 am
Is Bellerophon Therapeutics (BLPH) Outperforming Other Medical Stocks This Year?
- Jun 6th, 2023 1:40 pm
Bellerophon Announces Top-Line Data from Phase 3 REBUILD Clinical Trial of INOpulse® for Treatment of Fibrotic Interstitial Lung Disease
- Jun 5th, 2023 11:00 am
Bellerophon Therapeutics (NASDAQ:BLPH) delivers shareholders fantastic 978% return over 1 year, surging 18% in the last week alone
- May 17th, 2023 10:30 am
Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results
- May 15th, 2023 8:50 pm
Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease
- May 11th, 2023 12:30 pm
Bellerophon Therapeutics (BLPH) Outpaces Stock Market Gains: What You Should Know
- Apr 28th, 2023 9:50 pm
Scroll